基本信息
浏览量:603
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Professor Yellon organizes and runs annual, International & National medical educational meetings under the title of “Cardiology, Diabetes & Nephrology at the Limits”. These meetings are now in their 25th year.
Professor Yellon has published in excess of 600 papers and edited 23 books. He has a current h-index of 120 and was named as a Highly Cited Researcher for the past 4 years in the annual Web of Science report of highly cited researchers from across the world. The 2022 Edition of Ranking of Top 1000 international Scientists in the field of Medicine, mention that he is ranked #693 in the world and #78 in the UK. These rankings represent h-index, publications, involving a detailed examination of 166,880 researchers worldwide.
Professor Yellon runs a translational research Institute at UCL/UCLH and has successfully supervised over 80 clinicians & basic scientists for and degrees of MD(Res) & PhD degree) respectively. His main area of interest includes myocardial protection & the pathophysiology of cellular protection in the setting of diabetes, ischaemia/reperfusion injury, & molecular aspects to adaptation to ischaemic injury in both the basic and clinical arena.
He has further developed complementary research programmes including (both basic & clinical), protecting the heart in the setting of chronic kidney disease, ischaemic stroke and cardioprotection following cancer therapy.
Professor Yellon has published in excess of 600 papers and edited 23 books. He has a current h-index of 120 and was named as a Highly Cited Researcher for the past 4 years in the annual Web of Science report of highly cited researchers from across the world. The 2022 Edition of Ranking of Top 1000 international Scientists in the field of Medicine, mention that he is ranked #693 in the world and #78 in the UK. These rankings represent h-index, publications, involving a detailed examination of 166,880 researchers worldwide.
Professor Yellon runs a translational research Institute at UCL/UCLH and has successfully supervised over 80 clinicians & basic scientists for and degrees of MD(Res) & PhD degree) respectively. His main area of interest includes myocardial protection & the pathophysiology of cellular protection in the setting of diabetes, ischaemia/reperfusion injury, & molecular aspects to adaptation to ischaemic injury in both the basic and clinical arena.
He has further developed complementary research programmes including (both basic & clinical), protecting the heart in the setting of chronic kidney disease, ischaemic stroke and cardioprotection following cancer therapy.
研究兴趣
论文共 904 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Kishal Lukhna, Helison R. P. do Carmo, Alejandro Rossell Castillo,Sean M. Davidson, Hayli Geffen, Sara Giesz,Pelin Golforoush,Ticiane Goncalez Bovi, Diana Gorag,Alan Salama,Aqeela Imamdin, Siavash Kalkhoran,
CARDIOVASCULAR DRUGS AND THERAPYno. 3 (2024): 433-445
Journal of cellular and molecular medicineno. 6 (2024): e18152-e18152
Molecular genetics and metabolismno. 4 (2023): 107552-107552
Strokeno. 8 (2023): 2204-2207
HEART (2023): A307-A307
medRxiv (Cold Spring Harbor Laboratory) (2023)
Basic research in cardiologyno. 1 (2023): 22-9
Cardiovascular Drugs and Therapypp.1-5, (2023)
REDOX BIOLOGY (2023): 102894-102894
加载更多
作者统计
#Papers: 907
#Citation: 65131
H-Index: 126
G-Index: 234
Sociability: 8
Diversity: 3
Activity: 127
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn